Bisphosphonates for Osteoporosis  

Oleh:

Favus, Murray J.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 363 no. 21 (Nov. 2010), page 2027-2035.
Topik: BONE DISEASES; Osteoporosis; Metabolic Bone Disease
Fulltext: Dual-Energy X-Ray Absorptiometry (381.95KB)

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2010.01 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

A 67-year-old woman was referred by her primary care physician for treatment of osteoporosis and progressive bone loss. One year before the visit, the patient had discontinued hormone-replacement therapy. She had subsequently begun to experience midback pain and lost 3.8 cm (1.5 in.) in height. A dual-energy x-ray absorptiometry (DXA) scan showed bone mineral density T scores of -3.1 at the lumbar spine and -2.8 at the femoral neck, which are consistent with a diagnosis of osteoporosis. One year later, a second scan showed a further decrease of 5.4% in bone mineral density at the lumbar spine (Figure 1Figure 1 Dual-Energy X-Ray Absorptiometry (DXA) Scan of the Lumbar Spine.), as well as a compression fracture of the 11th thoracic vertebra (Figure 2Figure 2 Dual-Energy X-Ray Absorptiometry (DXA) Scan of the Thoracic and Lumbar Spine.). Results of blood and urine tests ruled out the common secondary causes of osteoporosis. To prevent additional vertebral fractures, oral bisphosphonate therapy was recommended.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali